Ambu A/S (OTCMKTS:AMBBY) Trading Down 2.2% – Should You Sell?

Ambu A/S (OTCMKTS:AMBBY)’s share price was down 2.2% on Wednesday . The company traded as low as $15.45 and last traded at $15.45. Approximately 500 shares changed hands during trading, an increase of 71% from the average daily volume of 293 shares. The stock had previously closed at $15.80.

Ambu A/S Price Performance

The company has a market capitalization of $3.63 billion and a P/E ratio of 128.75. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.52 and a quick ratio of 1.51. The company has a 50 day moving average of $18.17 and a 200-day moving average of $19.09.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings data on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $199.56 million for the quarter. Ambu A/S had a return on equity of 4.09% and a net margin of 4.30%.

Ambu A/S Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Monday, December 23rd. Shareholders of record on Friday, December 6th will be issued a $0.0557 dividend. The ex-dividend date of this dividend is Friday, December 6th.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.